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Compared with most European countries the UK
has a relatively long tradition of participation in cli-
nical audit following the publication in 1989 of a go-
vernment document ‘Working for Patients’ [1], which
recommended that audit be incorporated into routine
clinical practice. This paper enshrined the following
principles that embedded audit into clinical practice:
— every doctor should participate in regular sys-
tematic medical audit;
— the system should be medically led, with
a local medical audit advisory committee cha-
ired by a senior clinician;
— the overall form of audit should be agreed local-
ly between profession and management, which
itself needs to know that an effective system of
medical audit is in place and that the work of
each medical team is reviewed at regular and
frequent intervals to be agreed locally.
Initially clinicians took up this call by running
numerous local audits, which then, led by the Royal
Colleges responsible for training and professional stan-
dards, developed into an embryonic national audit
programme. Funding to the amount of GBP 220 mil-
lion (EUR 277,393,000/PLN 1,124,521,000) was pro-
vided centrally from Government to cover local audit
and now, via two regulatory bodies: the Health Quali-
ty Improvement Partnership (HQIP) and the National
Advisory Group on Clinical Audit and Enquiries, also
finances over 30 national audit programmes.
Respiratory physicians were in the forefront of
developing the national audit programme, and the
first attempt to establish a networked audit for ho-
spital COPD care was launched in 1997 by the Roy-
al College of Physicians of London (RCP) with a cli-
nician led audit of acute care in 42 hospitals that
recruited 1420 clinical cases [2]. A mixture of pro-
cess items and outcomes were recorded against
a background of clinical resources available to tre-
at COPD patients. This combination of clinical and
resource measures provided interesting comparators
which drove changes to future audits. Although
there were national audit funds available at that
time, COPD was not seen as a national priority and
so funding was hard to find. Eventually the Acade-
my of Colleges provided a grant of GBP 30,000 (EUR
37,700/PLN 153,300) to carry out a further pilot
audit programme at 30 hospital sites, designed to
explore different audit methods that would inform
an application for a truly national scale audit pro-
gramme for COPD. In this audit the data items were
extended to ensure that those found to be easily and
reliably collected were included whilst others were
dropped from the data set. New items of organisa-
tion of care and resources were included to explore
issues raised in the first audit, where size of hospi-
tal and staffing levels appeared to have some corre-
lation with outcomes [3]. Patient recruitment was
varied to include all patients admitted over a defi-
ned time period rather than capping numbers ente-
red by each hospital. Definitions of COPD exacer-
bation were tightened and process measures map-
ped to the BTS COPD management guidelines pu-
blished in 1997 [4]. Particular emphasis was placed
on regular contact with auditors at local sites to le-
arn more about the practicalities of data collection
at each hospital. This pilot provided invaluable in-
formation about those practical auditing issues and
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time, a survey of the experience of patients admit-
ted to hospital was also included in the audit as
was a survey of general practitioners who were
asked about the care of the same patients in the
run up period to their admission. Data were now
being collected across the patient pathway in
a major extension of the previous audit program-
me. The findings were remarkable with confirma-
tion of wide variations in clinical practice and high
levels of mortality and readmission rates [10] de-
spite the publication of a new set of national ma-
nagement guidelines [11]. Detailed analysis of NIV
outcomes revealed widespread use beyond the cri-
teria  derived from international RCT evidence
prompting the development of national guidelines
for NIV [12].
In particular the audit highlighted;
1. A high percentage of patients meeting the cri-
teria for NIV did not receive it.
2. NIV was the ceiling of treatment in many pa-
tients who died and did not receive IMV.
3. Many of the patients receiving NIV were very
acidotic and beyond the inclusion criteria of
the RCTs.
4. Some patients with a pure metabolic acidosis
received NIV inappropriately.
5.     Many patients were not treated in a ward area
with well trained staff.
6. A few centres still did not offer NIV.
7. Many centres were unable to provide NIV to
all patients who needed it.
As a result of these findings specific national
guidelines for the management of acidotic hyper-
capnic respiratory failure in COPD patients were
developed [13].
The results of the study at individual hospital
level were again distributed to clinical participants
and hospital chief executives with a brief summa-
ry of findings and action points. Summary reports
of each of the separate audit elements, e.g. hospi-
tal clinical, patient experience, resources and or-
ganisation, etc., were written and posted on the
three lead organisations’ web sites [14]. A patient-
friendly summary was distributed to patients, and
reports were disseminated to senior government
ministers and civil servants with responsibility for
COPD care. An official launch of the reports was
made at the Houses of Parliament with Minister of
Health a key speaker. The Clinical Audit leads were
granted meetings to discuss national results with
the four Medical Directors of the devolved coun-
tries of the UK: England, Northern Ireland, Scotland,
and Wales. Within a short time the headline results
had challenged the Department of Health to act and
a series of working parties were established to exa-
led to a publication guide for participation in futu-
re programmes [5] and confirmed a link between
resources available for care and both clinical pro-
cesses and outcomes [6].
At this stage the exciting data collected and the
experience of running larger scale audits combined
with the understanding of local issues in data col-
lection strengthened the case to bid for a national
COPD audit. The RCP combined forces with the Bri-
tish Thoracic Society (BTS) and applied successful-
ly to a pharmaceutical consortium for a grant, this
time of GBP 168,000 (EUR 211,300/PLN 858,700).
The audit data set again consisted of a cross sectio-
nal survey of resource and organisational items, e.g.
number of specialists per 1,000 admissions, use of
specialty triage, etc., coupled with a clinical audit of
process of care items, e.g. was an arterial blood gas
performed at admission and outcomes namely length
of stay, mortality, and readmission rates for survivors.
A major publicity campaign led by the RCP and BTS
resulted in 238 hospitals (96% of all eligible sites)
participating and collecting clinical data on 8013
admissions [7]. Reports on performance at individu-
al hospital level were sent to participating clinicians
and their hospital managers. Summary reports were
published on the RCP web site and were open ac-
cess [8]. Clinicians involved in the audit group le-
ading the programme led presentations and discus-
sions of data at regional meetings across the UK and
presented at the European Respiratory Society and
American Thoracic Society meetings. Key findings
from this audit were the massive variations in clini-
cal practice that existed between different hospitals
against the national guidelines. There was particu-
lar concern about the poor outcomes for patients tre-
ated with NIV compared to the RCT evidence that
provoked much debate [9].
Enthusiasm for clinical audit amongst clinicians
remained high, and using the data from the audit the
RCP and BTS now linked with the main patient sup-
port group for COPD in the UK, the British Lung Fo-
undation, to make a further financial bid this time to
the Health Foundation for a second audit round inc-
luding a change management intervention linking cli-
nical teams in two different hospitals to share good
practice and innovation in service delivery. The 2008
audit, like the audits of 2001 and 2003, was an itera-
tion of the previous data collection rounds informed
by practical issues and the challenges of the clinical
findings. Greater emphasis was placed on auditing
the clinical pathway for acidotic hypercapnic pa-
tients in an attempt to understand the findings of the
2003 audit. In recognition of the partnership with the
BLF and the movement of care from hospitals into
the community that was prevalent in the UK at that
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mine COPD care in England and Wales and separa-
tely in Northern Ireland and Scotland where respon-
sibility for health care was devolved to local mini-
sters. Regional meetings were arranged by the Depart-
ment of Health where members of the audit team
presented regional results highlighting variations
across hospitals and the overall high mortality, length
of stay, and readmissions whilst emphasising the
really good clinical practice and service innovation
that existed in some locations.
As a result of this gathering awareness of the
importance of COPD in terms of its prevalence and
impact on the health service resources and of course
on the morbidity and mortality amongst patients con-
cern and debate was translated into action. In 2010
the National Institute for Clinical Excellence (NICE)
produced revised COPD management guidelines [15],
and in 2011 NICE launched a series of COPD quality
standards designed to translate the management gu-
idelines into practical standards to be achieved at lo-
cal level [16]. Later that year the Department of He-
alth in England and Wales followed the strategies re-
leased by the Departments of Health in Northern Ire-
land and Scotland and produced the COPD and Asth-
ma Clinical Strategy that outlined the strategic direc-
tion that care for COPD as a long-term condition sho-
uld take [17]. In 2012 the Department produced a com-
missioning guide [18] to support those who contract
for COPD services, in order to understand what type
of service should be provided for COPD patients and
what outcome measures should be used to monitor
the success of those services. All of these documents
widely reference the national COPD audit program-
me, citing evidence from the data collection to sup-
port the recommendations that define minimum stan-
dards and outcome measures. Whilst it is clear that
the national audit programme alone cannot take all
the credit for this major shift in government policy in
placing huge emphasis on COPD care standards, the-
re is no doubt that without the audit programme the
impetus towards COPD would have been much we-
aker and undermined by the lack of credible clinical
data upon which to base a policy.
To bring this account up to the current position
the RCP/BTS/BLF has now joined with the Royal Col-
lege of General Practitioners and was awarded a con-
tract of GBP 3,000,000 (EUR 3,774,000/PLN
15,334,000) to deliver a COPD audit programme over
5 years that will now put greatest focus on care deli-
vered in the community by general practice whilst
continuing to collect data on patients admitted to ho-
spital with exacerbations, and new for this round, data
on the quality and outcomes of pulmonary rehabili-
tation programmes. Throughout all these elements of
audit will be an emphasis on the patient experience
of health care. The task is enormous: to enrol over 90%
of general practices with a longitudinal data collec-
tion of all COPD patients registered in those practices
and to provide data on over 95% of all hospitals!
Whilst we pale at the thought of the task ahead we
can only marvel at the change in priority COPD now
has when 15 years ago we were unable to source GBP
1 (EUR 1.26) from the government yet we now have a
five-year programme fully funded and commissioned
by those who oversee our national health service!
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